Background and Purpose-Minimally invasive surgery (MIS) for intracerebral hemorrhage (ICH) has been evaluated in numerous clinical trials. Although meta-analyses for this strategy have been performed in the past, recent trials add important information to results of the comparison and permit strategy-specific analyses, including evaluation of endoscopic evacuation and stereotactic thrombolysis. Methods-Major scientific databases including but not limited to Pubmed, the CENTRAL (Cochrane Central Register of Controlled Trials), Embase, Web of Science, Scopus, the ICTRP (International Clinical Trials Registry Platform), the Internet Stroke Center, and the CNKI (Chinese National Knowledge Infrastructure) were searched in October of 2017 for randomized controlled trials of MIS treatment of supratentorial spontaneous ICH. The primary outcome was defined as death or dependence at the end of follow-up, and the secondary outcome was defined as death. Results-The initial search yielded 958 reports, which were reduced to 15 high-quality randomized controlled trials involving 2152 patients. We analyzed odds ratios for MIS overall, endoscopic surgery, and stereotactic thrombolysis compared with conventional treatment, including medical treatment and conventional craniotomy. 
S
pontaneous intracerebral hemorrhage (ICH) accounts for 2 million strokes worldwide per year and is the most deadly subtype of stroke with a 1-year mortality rate up to 50%. 1 Among survivors, 61% to 88% are dependent on others for activities of daily living 6 months after the hemorrhage. 2 Given the high morbidity and mortality of this disease process, surgical options have been repeatedly evaluated in large multicenter randomized controlled trials (RCTs) that unfortunately have not demonstrated improved outcomes. In parallel, RCTs have been performed to evaluate minimally invasive surgery (MIS) in comparison to either medical therapy or conventional craniotomy with varying degrees of success with different surgical techniques and in different patient subgroups.
Ongoing RCTs include the National Institutes of Healthsponsored MISTIE trial (Minimally Invasive Surgery Plus rt-PA for ICH Evacuation) evaluating stereotactic thrombolysis, the endoscopic arm of MISTIE referred to as the ICES trial (Intraoperative Stereotactic Computer TomographyGuided Endoscopic Surgery) and 2 industry-sponsored trials, including the ENRICH trial (Early Minimally-Invasive Removal of Intracerebral Hemorrhage) sponsored by NICO Corporation and the INVEST (Minimally Invasive Endoscopic Surgical Treatment With Apollo/Artemis in Patients With Brain Hemorrhage) trial sponsored by Penumbra. [3] [4] [5] [6] Each of these trials is minimally invasive but employs a different strategy for patient selection and evacuation. A previous meta-analysis published in 2012 compared MIS to medical treatment and conventional craniotomy but did not have sufficient data to compare MIS subgroups and suffered from methodological errors. 7, 8 This updated meta-analysis incorporates multiple recent RCTs to evaluate MIS technique subgroups, as well as important patient-selection subgroups for time to evacuation. Understanding the effect of MIS for ICH in these technique subgroups and patient-selection subgroups will contribute to planning for future clinical trials.
Methods

Study Design
We performed a systematic review and study-level meta-analysis of RCTs evaluating MIS techniques in the treatment of spontaneous ICH according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 9 Details of the protocol for this analysis were registered (CRD4201807955) on the online database International Prospective Register of Systematic Reviews (PROSPERO) and can be accessed at https://www.crd.york.ac.uk/PROSPERO/display_ record.asp?ID=CRD42018079755.
The authors declare that all supporting data are available within the article.
We included only RCTs evaluating MIS approaches to spontaneous ICH to minimize selection and confounding biases of prospective observational studies. The study groups were defined by randomized assignment to either minimally invasive surgical ICH evacuation versus non-MIS treatment, including medical therapy and conventional craniotomy. Authors Drs Scaggiante and Kellner then reviewed the methodology of each study to determine which MIS technique was used. If surgery was defined as minimally invasive by the authors, it was included in the MIS group. If an endoscope was used during the evacuation, the technique was categorized as endoscopic surgery. If a device or catheter was stereotactically placed for infusion of a thrombolytic agent and drainage of the hematoma beyond the time of the operative procedure, the technique was categorized as stereotactic thrombolysis.
The prespecified primary endpoints were significant neurological debilitation or death defined as modified Rankin Scale score of ≥3 or Barthel Index ≤60 when modified Rankin Scale was not available. Outcome measures analyzed were those used in the original studies with some variability in the point in scale used to dichotomize good and poor outcome. The modified Rankin Scale and Barthel Index have high reproducibility and are commonly used to assess neurological outcome in ICH. [10] [11] [12] [13] [14] The secondary end point was death alone. All end points were estimated at the maximum time of follow-up reported according to the intentionto-treat principle.
Research Strategy
Using the Cochrane systematic approach and the PRISMA 2009 guidelines, we searched major scientific databases including but not limited to Pubmed, the CENTRAL, Embase, Web of Science, Scopus, the ICTRP, the Internet Stroke Center, and the CNKI up to October 2017 with different combinations of the following words: spontaneous or intracranial or intracerebral or cerebral or brain or putaminal or intraparenchymal or basal ganglia or thalamic or h(a)emorrhage or h(a)emorrhagic or stroke or h(a)ematoma or minimally invasive or minimal surgical procedures or endoscopy(ic) or stereotaxy(ic) or aspiration or keyhole or burrhole or craniopuncture or evacuation or randomized or controlled or surgery.
We obtained additional articles using reference lists of articles identified in the initial searches.
Inclusion criteria were (1) computed tomography-confirmed diagnosis of spontaneous ICH and (2) RCTs comparing MIS techniques with other treatment options, including conventional medical management and craniotomy. Exclusion criteria were (1) traumatic brain injury, hemorrhagic tumor, coagulopathy, intracranial aneurysm, cerebral arteriovenous malformation, subdural hemorrhage, epidural hemorrhage, subarachnoid hemorrhage, or pituitary apoplexy; (2) infratentorial ICH, including cerebellar hemorrhage or brain stem hemorrhage; and (3) a total study quality assessment score of <2. The study quality assessment referred to the Cochrane criteria: (1) random sequence generation (yes=2, unclear=1, and no=0); (2) allocation concealment (yes=2, unclear=1, and no=0); (3) blinding of outcome assessment (yes=2, unclear=1, and no=0); and (4) incomplete outcome data reported (yes=1 and no=0).
Data Extraction and Analysis
Two authors (Drs Scaggiante and Kellner) independently identified the articles by inclusion and exclusion criteria, and study quality assessment scores were assigned. Any disagreements were resolved by consensus with a third investigator (Dr Mocco).
First, we compared outcomes in MIS versus other treatments. Second, we performed subgroup analyses according to the type of MIS technique performed. We also conducted subgroup analyses focusing on time of ictus to evacuation analyzing studies with time to evacuation ≤24 hours together and separately analyzing studies with time to evacuation ≤72 hours.
The primary and secondary outcomes of the study were analyzed as categorical variables with the effectiveness for different treatment methods evaluated and interpreted with a summary odds ratio (OR) and the corresponding 95% CI. Classic χ2 test, Q 2 , and I 2 statistics were used to assess the existence and magnitude of between-study heterogeneity. 15 The significance level was set at 0.05. In the analysis, we used the random-effects model. We assumed a priori that the meta-analysis can be affected by studylevel variability determined by different inclusion criteria across RCTs, which is more appropriately addressed by a random-effects model over a fixed-effect model.
Inverted funnel plots and a regression test were used to assess the potential presence of publication bias. All data analyses were conducted and testified by both R (VERSION 3.4.1) and RevMan5 (Cochrane Information Management System). 
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Results
The initial search yielded 958 reports which were screened to 380 documents after removing duplicates. Two-hundred eighty-six reports were removed because the titles did not meet the inclusion criteria. Seventy-one reports were removed after the 2 reviewers (Drs Scaggiante and Kellner) independently read the abstract and full texts and determined that the reports did not meet inclusion criteria. Therefore, 23 RCTs were included in the assessment for study quality. The assessment for study quality eliminated an additional 8 studies. Thus, we reduced 958 reports to 15 high-quality RCTs involving 2152 patients eligible for inclusion in the metaanalysis (Figure 1) . In 2 analyses, the subjects from 1 study, Miller et al, 16 all experienced the same outcome making an OR for this subgroup not estimable within the study. These subjects and events were still included in the overall subgroup meta-analysis ( Figure 2 ). In the MIS group, 8 studies involved stereotactic thrombolysis, 1 involved stereotactic aspiration, 5 involved endoscopic surgery, and 1 involved both stereotactic thrombolysis and endoscopic surgery.
For the non-MIS group, 9 trials compared MIS with medical treatment and 6 compared MIS with conventional craniotomy (Table 1) . Baseline characteristics, including type of treatment and length of follow-up, are shown in Table 2 .
Fourteen studies provided sufficient data to assess the primary outcome measure of significant functional impairment or death (Figure 2 
Discussion
In this systematic review and meta-analysis, we have incorporated recent data to reevaluate the total effect of MIS in the treatment of ICH, as well as the effect of specific techniques, including endoscopic surgery and stereotactic thrombolysis. We found that both techniques independently seem to decrease the rate of moderate to severe functional impairment and death at long-term follow-up. In addition, we performed subgroup analyses focusing on time from ictus to evacuation demonstrating that MIS techniques seem beneficial in both the 24-hour time window and the 72-hour time window.
Study design, including the primary and secondary outcome measures, and subgroup analyses were modeled after those in prior meta-analyses on this topic performed by Prasad et al 29 and Zhou et al 7 to permit direct comparison. Previous authors have identified inaccuracies in Zhou et al, including miscategorization of the time to treatment and outcome measure used in Mendelow et al. 8, 30 The reference for one of the studies categorized as stereotactic aspiration by Zhou et al, with the first 7 in that we have included craniopuncture as stereotactic thrombolysis given the commonality of the treatment strategy, which includes placement of a device or catheter and removal of the hematoma over multiple days with the infusion of a thrombolytic agent. Additionally, we have not included the data from Mendelow et al 31 in our subgroup analysis given that the subgroup outcomes are not published.
Recent studies that justify this update and permit novel subgroup analyses include data from 2014 by Zhang et al, 26 from 2016 by Yang et al, 28 from 2016 by Feng et al, 27 from phase 2 of the MISTIE trial, and from the ICES study. 3, 6 Specifically, 2 RCTs 3,28 were added to the stereotactic thrombolysis subgroup and 3 RCTs 6, 26, 27 to the endoscopic surgery subgroup, increasing statistical power and permitting direct comparison of each specific MIS technique against conventional therapy. No trials yet compare endoscopic surgery to stereotactic thrombolysis nor is it possible to directly compare the effects of the 2 techniques with the available data.
This study directly compared MIS evacuation to other treatments, including medical management or craniotomy, demonstrating that morbidity and mortality improved significantly in the MIS group over the other treatment group. In this analysis, MIS evacuation increased the chance of being independent at follow-up by 2.2× and survival at follow-up by 1.7×. This study also compared MIS evacuation to craniotomy alone, demonstrating that MIS evacuation increases the chance of being independent at follow-up by 2.3× and survival at follow-up by 1.8×. The prior meta-analysis on this topic, Zhou et al, 7 found that MIS evacuation did not demonstrate a significant benefit over craniotomy. Three RCTs performed since 2012 have influenced this analysis to now demonstrate superiority of MIS evacuation versus craniotomy.
Endoscopic surgery specifically was associated with a 2.5× increased chance of reaching functional independence when compared with other treatments and a 2.7× increased chance of survival. The ongoing trials ICES and INVEST will directly address the effect of endoscopic evacuation. 5, 6 Analysis of stereotactic thrombolysis specifically demonstrates that it increases the chance of good functional outcome 2.1× over conventional therapy although it did not seem to convey a survival benefit. This result is consistent with the data presented in phase 2 of MISTIE, which demonstrated a similar rate of death in the medical and treatment arms at 6 months and 1 year. 3 The ICES trial reporting cases treated with endoscopic surgery, by contrast, did demonstrate a substantial difference in the proportion of patients alive at 1 year reporting 58% survival in the medical arm and 84% survival in the endoscopic surgery arm. Further evaluation of this effect is underway in phase 3 of the MISTIE trial. 
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hours of ictus and STICH II requiring evacuation within 60 hours of ictus. 30, 31 Ongoing MIS trials also vary in time to evacuation with MISTIE and INVEST requiring evacuation within 72 hours but ENRICH requiring evacuation within 24 hours. Subgroup analyses of data from these trials in the future may demonstrate the effect of time to evacuation on long-term outcome. This meta-analysis demonstrates that patients who underwent MIS evacuation within 24 hours were 2.8× more likely to achieve functional independence whereas patients who underwent MIS evacuation within 72 hours were 2× more likely to reach functional independence. Although early evacuations may be driving the results in both groups, a comparative subgroup analysis is not possible in the published data. It is possible to conclude that trials with a time to evacuation up to 72 hours have demonstrated efficacy over conventional therapy.
Other subgroup analyses focusing on critical details, such as hematoma volume, patient age, and follow-up timing are highly desirable and would inform future clinical trial design. The high variability of inclusion criteria among the 15 published RCTs, however, make it impossible to perform clinically meaningful study-level subgroup analyses on any of these clinical details. Patient-level subgroup analyses may be possible if data from ongoing trials is compiled and analyzed at the conclusion of these studies.
Limitations
Meta-analyses are classically limited by the heterogeneity of the inclusion and exclusion criteria of the examined studies, as well as the variability of the outcome measure. In these studies, the definition of good functional outcome varied, such as in Zhang et al in which good outcome was defined as modified Rankin Scale score of ≤3 and in Yang et al in which good outcome was defined as Barthel Index >80. In some cases, outcomes for both the primary and secondary outcome were not available, such as in Cho et al and Yang et al. The conclusions of this metaanalysis are, therefore, limited by the quality and heterogeneity of the data included. Although not perfectly homogenous, the large number of studies permit some quantitative analyses that may inform future trial design and clinical practice.
Conclusions
MIS for ICH evacuation is supported by a meta-analysis of existing RCTs. Recent trials permit subgroup analyses of specific surgical techniques, which will become increasingly relevant as ongoing trials evaluating these individual techniques complete enrollment.
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